ArticleJournal of cellular and molecular medicine2024

Downregulation of GLYAT correlates with tumour progression and poor prognosis in hepatocellular carcinoma.

Fengchen Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.